UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Nuria Seto-Salvia
1st floor
1 Wakefield Street
Queens Square Brain Bank, Institute of Neurology
London
United Kingdom
WC1N 1PJ
Appointment
  • Research Associate
  • Molecular Neuroscience
  • Institute of Neurology
  • Faculty of Brain Sciences
Research Themes
Research Summary

Dr Núria Setó-Salvia, a Spanish Postdoctoral Neuroscientist with a strong background in the genetics of neurodegenerative diseases. Núria has taken up the challenge of investigating the molecular biology of tau mutations in frontotemporal dementia and corticobasal degeneration (CBD). Corticobasal degeneration is known as a ‘tauopathy’ in which different types of cells in the brain progressively die due to abnormal accumulation of the protein tau. Skin cells from people with a genetic mutation in their DNA that leads to a condition with similar clinical and pathological features to CBD are taken. Dr Setó-Salvia then manipulates these cells to become brain cells, producing a model of disease that can be grown in a culture dish in the laboratory to replicate what is happening in the brain. The project utilises a range of experimental scientific methods to compare the cellular mechanisms of CBD patients with those of healthy individuals, in an attempt to explain why the abnormal tau protein makes brain cells vulnerable and leads to their death. Understanding these changes could aid the development of new drugs to reverse these defects and thereby halt or slow the progression of the disease. In the longer term pluripotent stem cells also hold great promise in the field of regenerative medicine, as they may allow replacement of damaged or dead brain cells with those developed in culture.

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by